Aller au contenu principal
Profil bibliographique

A. Gintsburg

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

13Publications signalées
93Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Cystic Fibrosis Research AdvancesSARS-CoV-2 and COVID-19 ResearchVirus-based gene therapy researchMonoclonal and Polyclonal Antibodies ResearchBacteriophages and microbial interactions

Les publications récentes

Accès ouvert 2025 article OpenAlex

Single-Dose Intranasal or Intramuscular Administration of Simian Adenovirus-Based H1N1 Vaccine Induces a Robust Humoral Response and Complete Protection in Mice

Daria V. Voronina, Irina V. Vavilova, Olga V. Zubkova, Tatiana A. Ozharovskaia et autres

Despite the widespread accessibility of vaccines and antivirals, seasonal influenza virus epidemics continue to pose a threat to public health. In this study, we constructed a recombinant replication-deficient simian adenovirus type 25 vector carrying the full-length hemagglutinin (HA) of the H1N1 influenza …

ru (code pays fourni par la source)

2 citations Viruses
2023 article OpenAlex

Preparation and Crystallographic Analysis of a Complex of SARS-CoV-2 S-Protein Receptor-Binding Domain with a Virus-Neutralizing Nanoantibody

Konstantin M. Boyko, Larisa A. Varfolomeeva, Nikita A. Egorkin, Mikhail E. Minyaev et autres

Abstract Coronavirus SARS-CoV-2 was the cause of global pandemic COVID-19 that has claimed millions of lives around the world. One of the approaches to the therapy of severe forms of COVID-19 is based on the use of virus-neutralizing antibodies against the receptor-binding …

ru (code pays fourni par la source)

4 citations Crystallography Reports
Accès ouvert 2022 article OpenAlex

Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern

I. A. FAVORSKAYA, Dmitry V. Shcheblyakov, I. B. Esmagambetov, Inna V. Dolzhikova et autres

Virus-neutralizing antibodies are one of the few treatment options for COVID-19. The evolution of SARS-CoV-2 virus has led to the emergence of virus variants with reduced sensitivity to some antibody-based therapies. The development of potent antibodies with a broad spectrum of neutralizing …

ru (code pays fourni par la source)

39 citations Frontiers in Immunology
Accès ouvert 2021 preprint OpenAlex

Single-domain antibodies efficiently neutralize SARS-CoV-2 variants of concern, including Omicron variant

I. A. FAVORSKAYA, Dmitry V. Shcheblyakov, I. B. Esmagambetov, Inna V. Dolzhikova et autres

ABSTRACT Virus-neutralizing antibodies are one of the few treatment options for COVID-19. The evolution of SARS-CoV-2 virus has led to the emergence of virus variants with reduced sensitivity to some antibody-based therapies. The development of potent antibodies with a broad spectrum of …

ru (code pays fourni par la source)

1 citation bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2019 article OpenAlex

RESPIRATORY TRACT MICROBIOME IN CHILDREN WITH CYSTIC FIBROSIS

Н. Н. Рыжова, Olga L. Voronina, E. V. Loseva, Ekaterina I. Aksenova et autres

МИКРОБИОМ РЕСПИРАТОРНОГО ТРАКТА ДЕТЕЙ С МУКОВИСЦИДОЗОМ Н. Н. Рыжова 1 , О. Л. Воронина 1 , Э. В. Лосева 2 , е. И. Аксенова 1 , М. С. Кунда 1 , Н. е.Шарапова 1 , В. Д. Шерман 3 , А. Л. …

ru (code pays fourni par la source)

3 citations Siberian medical review
Accès ouvert 2019 article OpenAlex

Использование гликопротеина GP для создания универсальной вакцины против лихорадки Эбола

Inna V. Dolzhikova, Amir I. Tukhvatulin, Anastasia S. Gromova, Daria M. Grousova et autres

Болезнь, вызванная вирусом Эбола (БВВЭ) — одно из самых высоколетальных вирусных заболеваний, поражающих человека и приматов. Возбудителем БВВЭ является вирус Эбола. В настоящее время известно шесть видов этого вируса, три из них патогенны для человека — это виды Заир (ZEBOV), Судан (SUDV) …

0 citations Вестник Российского государственного медицинского университета

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.